Allied Minds (ALM)
Due to recent changes by the London Stock Exchange relating to MiFID II, some AIM stocks are trading off‑book and therefore not showing recent prices, price changes or trades. We are working with the LSE to improve this situation.
ALM Share PerformanceMore
|52 week high||475.00 04/01/17|
|52 week low||114.00 24/08/17|
|52 week change||-201.15 (-55.43%)|
|4 week volume||3,533,526 29/10/17|
Latest News« previous» nextMore
13/11/2017 - 16:42 RNS
RNS Number: 3639W Allied Minds PLC 13 November 2017 Allied Minds plc BLOCK LISTING SIX MONTHLY RETURN Date: 13 November 2017 Name of applicant: Allied Minds plc Name of scheme: 2014 Long Term Incentive Plan Period of return: From: 12 May 2017 To: 12 November 2017 Balance of unallotted securities under scheme(s) from previous return: 6,56...
13/11/2017 - 16:24 RNS
RNS Number: 3628W Allied Minds PLC 13 November 2017 Allied Minds plc BLOCK LISTING SIX MONTHLY RETURN Date: 13 November 2017 Name of applicant: Allied Minds plc Name of scheme: 2008 Stock Option Plan / Issuance Plan Period of return: From: 19 May 2017 To: 12 November 2017 Balance of unallotted securities under scheme(s) from previous retu...
03/11/2017 - 16:11 Interactive Investor
Neil Woodford is not the only big name to produce below-par performance recently. Kyle Caldwell looks at others who ha...
31/10/2017 - 16:47 RNS
RNS Number: 1602V Allied Minds PLC 31 October 2017 31 October 2017 Allied Minds plc: Total Voting Rights and Share Capital - Month End Disclosure Pursuant to DTR 5.6.1 of the Disclosure Guidance and Transparency Rules: As at 31 October 2017 the issued share capital of Allied Minds plc comprised 238,190,661 Ordinary sharesof one pence each. There were no shar...
30/10/2017 - 08:16 StockMarketWire
Allied-Bristol Life Sciences - a biopharmaceutical enterprise jointly owned by Allied Minds and Bristol-Myers Squibb Co - ...
30/10/2017 - 07:00 RNS
RNS Number: 9014U Allied Minds PLC 30 October 2017 Allied-Bristol Life Sciences forms ABLS IV ABLS IV to carry out feasibility studies on a novel class of inhibitors of immunoproteasome for treatment of autoimmune diseases, including lupus and rheumatoid arthritis, licensed from Cornell University Boston (30October 2017)- Allied-Bristol Life Sciences, LLC (...
25/10/2017 - 06:00 RNS
RNS Number: 5191U Allied Minds PLC 25 October 2017 Allied Minds announces date for Capital Markets Day: 18 January 2018 Boston - 25 October 2017 - Allied Minds (ALM: LSE) today announces it will host a Capital Markets Day (CMD) for investors and analysts in London on 18 January 2018. The CMD will be focused on Allied Minds top subsidiaries. There will b...
16/10/2017 - 07:08 StockMarketWire
Allied Minds subsidiary Spin Transfer Technologies and Tokyo Electron have signed an agreement for a collaborative eng...
Latest discussion posts More
“Had a quick look at chart was around 425p.... 20 Nov 2015.. good job i didn't buy it. Maybe a death cross 20 March 17 ?..... it dropped to 118p !!... ( not a chart man lol ...”▼
“Nearly two years since i looked in here . Never see a post that's not derogatory about Woodford.”▼
“Games, I wonder if Woody ever reflects on the wise words of the King ... Elvis ... "We're caught in a trap ... I can't walk out ... Because I love you too much, ...”▼
Codes & Symbols
|Symbols||ALM, LSE:ALM, ALM.L, ALM:LN, LON:ALM, XLON:ALM|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment